2020
Protocol registration issues of systematic review and meta-analysis studies: a survey of global researchers
Tawfik G, Giang H, Ghozy S, Altibi A, Kandil H, Le H, Eid P, Radwan I, Makram O, Hien T, Sherif M, Hossain A, Thang T, Puljak L, Salem H, Numair T, Moji K, Huy N. Protocol registration issues of systematic review and meta-analysis studies: a survey of global researchers. BMC Medical Research Methodology 2020, 20: 213. PMID: 32842968, PMCID: PMC7448304, DOI: 10.1186/s12874-020-01094-9.Peer-Reviewed Original ResearchConceptsProtocol registrationMethodsA cross-sectional survey studyCross-sectional survey studySurvey studySystematic reviews/meta-analysisMeta-analysis studySR/MAsSystematic reviewConclusionAbout halfCochrane guidelinesMeta-analysisSR/MALiterature searchIncreased awarenessOnline questionnaireParticipantsProtocol registryPROSPEROE-mailScopus databasesSurveyProtocol databaseAwarenessDatabaseRegistration process
2017
Role of molecular markers to predict distant metastasis in papillary thyroid carcinoma: Promising value of TERT promoter mutations and insignificant role of BRAF mutations—a meta-analysis
Vuong H, Altibi A, Duong U, Ngo H, Pham T, Tran H, Oishi N, Mochizuki K, Nakazawa T, Hassell L, Katoh R, Kondo T. Role of molecular markers to predict distant metastasis in papillary thyroid carcinoma: Promising value of TERT promoter mutations and insignificant role of BRAF mutations—a meta-analysis. Tumor Biology 2017, 39: 1010428317713913. PMID: 29037127, DOI: 10.1177/1010428317713913.Peer-Reviewed Original ResearchConceptsPapillary thyroid cancerTERT promoter mutationsDistant metastasisThyroid cancerPromoter mutationsRET/PTC rearrangementsBRAF mutationsPresence of distant metastasesAssessment of patient prognosisTumor risk stratificationAssociated with distant metastasisPapillary thyroid carcinomaMeta-analysisPredicting distant metastasisAssociation of BRAFRandom-effects modelThyroid carcinomaTERT promoterRisk stratificationPatient prognosisRAS mutationsAdverse outcomesMetastasisIncreased riskBRAF
2016
Therapeutic efficacy and safety of Botulinum Toxin A Therapy in Trigeminal Neuralgia: a systematic review and meta-analysis of randomized controlled trials
Morra M, Elgebaly A, Elmaraezy A, Khalil A, Altibi A, Vu T, Mostafa M, Huy N, Hirayama K. Therapeutic efficacy and safety of Botulinum Toxin A Therapy in Trigeminal Neuralgia: a systematic review and meta-analysis of randomized controlled trials. The Journal Of Headache And Pain 2016, 17: 63. PMID: 27377706, PMCID: PMC4932020, DOI: 10.1186/s10194-016-0651-8.Peer-Reviewed Original ResearchConceptsRandomized controlled trialsTrigeminal neuralgiaBTX-AMeta-analysisSafety of BTX-AEfficacy of botulinum toxin type AMeta-analysis of randomized controlled trialsControlled trialsSystematic reviewRecurrent pain attacksTreatment of TNPublished randomized controlled trialsNo significant heterogeneityBTX-A groupBotulinum toxin type ABotulinum toxin A therapyPain attacksTN patientsToxin type AA therapyClinical outcomesTreatment optionsTherapeutic efficacyQuality of lifeProportion of respondents